Barinthus Biotherapeutics Plc Adr (BRNS)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Barinthus Biotherapeutics Plc Adr-Aktie (BRNS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	1,100% 0.156	0.013	0.329	-	14.97
Operating Expenses	34.77% 15.22	23.34	20.93	23.57	24.56
Benefits Costs and Expenses	30.08% 14.80	21.16	20.01	20.59	23.10
Costs And Expenses	34.77% 15.22	23.34	20.93	20.59	23.10
Other Operating Income/Expenses	1,100% 0.156	0.013	0.329	0.184	0.21
Operating Income/Loss	35.41% -15.07	-23.32	-20.60	-23.39	-9.38
Nonoperating Income/Loss	80.49% 0.424	2.173	0.92	2.802	1.248
Income/Loss From Continuing Operations Before Tax	30.77% -14.64	-21.15	-19.68	-20.59	-8.132
Income Tax Expense/Benefit, Deferred	184.00% -0.071	-0.025	-0.022	0.003	-0.003
Income Tax Expense/Benefit	184.00% -0.071	-0.025	-0.022	0.003	-0.003
Income/Loss From Continuing Operations After Tax	31.03% -14.57	-21.13	-19.66	-20.59	-8.129
Net Income/Loss	31.03% -14.57	-21.13	-19.66	-20.59	-8.129
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	150.00% -0.005	-0.002	-0.01	-0.051	-0.015
Basic Average Shares	0.79% 40.66	40.34	40.27	0.269	39.42
Diluted Average Shares	0.79% 40.66	40.34	40.27	0.269	39.42
Basic Earnings Per Share	30.77% -0.36	-0.52	-0.49	-0.51	-0.21
Diluted Earnings Per Share	30.77% -0.36	-0.52	-0.49	-0.51	-0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-